Angiotensin-Converting Enzyme Inhibitory Effects by Plant Phenolic Compounds: A Study of Structure Activity Relationships

被引:168
作者
Al Shukor, Nadin [1 ,2 ,3 ]
Van Camp, John [2 ]
Gonzales, Gerard Bryan [1 ,2 ,3 ]
Staljanssens, Dorien [1 ,2 ]
Struijs, Karin [2 ]
Zotti, Moises J. [1 ,4 ]
Raes, Katleen [3 ]
Smagghe, Guy [1 ]
机构
[1] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium
[2] Univ Ghent, Fac Biosci Engn, Dept Food Safety & Food Qual, B-9000 Ghent, Belgium
[3] Univ Ghent, Fac Biosci Engn, Dept Ind Biol Sci, B-8500 Kortrijk, Belgium
[4] Univ Fed Santa Maria, Lab ChemoGen & Bioinformat, Dept Crop Protect, BR-97105900 Santa Maria, RS, Brazil
关键词
hypertension; angiotensin-converting enzyme; phenolic compounds; molecular docking; structure-activity relationship; FLAVONOIDS; PROTEIN; POLYPHENOLS; BRADYKININ; PEPTIDES; TANNINS; KIDNEY; SALIVA; ASSAY;
D O I
10.1021/jf404641v
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
In this study, 22 phenolic compounds were investigated to inhibit the angiotensin-converting enzyme (ACE). Tannic acid showed the highest activity (IC50 = 230 mu M). The IC50 values obtained for phenolic acids and flavonoids ranged between 0.41 and 9.3 mM. QSAR analysis confirmed that the numbers of hydroxyl groups on the benzene ring play an important role for activity of phenolic compounds and that substitution of hydroxyl groups by methoxy groups decreased activity. Docking studies indicated that phenolic acids and flavonoids inhibit ACE via interaction with the zinc ion and this interaction is stabilized by other interactions with amino acids in the active site. Other compounds, such as resveratrol and pyrogallol, may inhibit ACE via interactions with amino acids at the active site, thereby blocking the catalytic activity of ACE. These structure function relationships are useful for designing new ACE inhibitors and potential blood-pressure-lowering compounds based on phenolic compounds.
引用
收藏
页码:11832 / 11839
页数:8
相关论文
共 45 条
[21]   Dietary flavonoids: Intake, health effects and bioavailability [J].
Hollman, PCH ;
Katan, MB .
FOOD AND CHEMICAL TOXICOLOGY, 1999, 37 (9-10) :937-942
[22]   ACE inhibition and bradykinin-mediated renal vascular responses - EDHF involvement [J].
Imig, JD .
HYPERTENSION, 2004, 43 (03) :533-535
[23]   COUGH AND ANGIONEUROTIC-EDEMA ASSOCIATED WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY - A REVIEW OF THE LITERATURE AND PATHOPHYSIOLOGY [J].
ISRAILI, ZH ;
HALL, WD .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :234-242
[24]   Molecular model for astringency produced by polyphenol/protein interactions [J].
Jöbstl, E ;
O'Connell, J ;
Fairclough, JPA ;
Williamson, MP .
BIOMACROMOLECULES, 2004, 5 (03) :942-949
[25]   QUANTITATIVE-DETERMINATION OF TANNIN AND PROTEIN IN THE PRECIPITATES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
KAWAMOTO, H ;
NAKATSUBO, F ;
MURAKAMI, K .
PHYTOCHEMISTRY, 1995, 40 (05) :1503-1505
[26]  
Kuhnau J, 1976, World Rev Nutr Diet, V24, P117
[27]   Spectroscopic and theoretical studies of the Zn(II) chelation with hydroxyflavones [J].
Lapouge, Christine ;
Dangleterre, Laetitia ;
Cornard, Jean-Paul .
JOURNAL OF PHYSICAL CHEMISTRY A, 2006, 110 (45) :12494-12500
[28]   Antihypertensive effects of tannins isolated from traditional Chinese herbs as non-specific inhibitors of angiontensin converting enzyme [J].
Liu, JC ;
Hsu, FL ;
Tsai, JC ;
Chan, P ;
Liu, JYH ;
Thomas, GN ;
Tomlinson, B ;
Lo, MY ;
Lin, JY .
LIFE SCIENCES, 2003, 73 (12) :1543-1555
[29]   Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease -: The task force on ACE-inhibitors of the European Society of Cardiolgy [J].
López-Sendón, J ;
Swedberg, K ;
McMurray, J ;
Tamargo, J ;
Maggioni, AP ;
Dargie, H ;
Tendere, M ;
Waagstein, F ;
Kjekshus, J ;
Lechat, P ;
Torp-Pedersen, C .
EUROPEAN HEART JOURNAL, 2004, 25 (16) :1454-1470
[30]   Polyphenols:: food sources and bioavailability [J].
Manach, C ;
Scalbert, A ;
Morand, C ;
Rémésy, C ;
Jiménez, L .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 79 (05) :727-747